Please assess the completion status of the following clinical trial:

Trial Title: Colchicine in Coronary Artery Bypass Graft (CABG)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The study will enroll patients 18 years old or older who are eligible to undergo CABG surgery.~Exclusion Criteria:~Excluded are patients:~* with age \> 80 years old~* scheduled for concomitant valve surgery~* scheduled for coronary surgery without cardiopulmonary bypass~* with peripheral vascular disease aﬀecting the upper limbs~* with acute coronary syndrome within the previous 4 weeks~* on inotropic or mechanical circulatory support before induction of anaesthesia~* with any disorder that could potentially increase preoperative cTnI concentrations (eg, percutaneous coronary intervention within the previous 6 weeks)~* with active inflammatory diseases, infectious diseases or known malignancy~* under treatment with corticosteroids, anti-inflammatory agents or disease modifying agents~* with known hypersensitivity-allergy to colchicine~* under chronic treatment with colchicine~* with severe renal failure (eGFR \< 35 ml/min/1.73 m2)~* with hepatic failure (Child - Pugh class B or C)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Control group (Type: PLACEBO_COMPARATOR): Patients taking placebo
- Colchicine (Type: EXPERIMENTAL): Active treatment group

Based on this trial design, predict the completion outcome and termination type (if applicable).